James G. Kotsanos

Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 337 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Potential Economic Benefits of Lower-Extremity Amputation Prevention Strategies in Diabetes

Daniel A. Ollendorf, James G. Kotsanos, William J Wishner et al. · Diabetes Care · 1998 · 308 citations

Health Professions, Health Policy, Pharmacoeconomics +13

Model of Complications of NIDDM: I. Model construction and assumptions

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 260 citations

Medicine, Biostatistics, Nephrology +17

Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy

James G. Kotsanos, Louis Vignati, William J. Huster et al. · Diabetes Care · 1997 · 119 citations

Medicine, Endocrinology, Pharmacotherapy +14

Development and Validation of the Diabetes Quality of Life Clinical Trial Questionnaire

Wei Shen, James G. Kotsanos, William J. Huster et al. · Medical Care · 1999 · 109 citations

Social Sciences, Internal Medicine, Health Assessment +16